PQBP-1, a novel polyglutamine tract-binding protein, inhibits transcription activation by Brn-2 and affects cell survival

Human Molecular Genetics

Volumn 8, Issue 6, 1999, Pages 977-987

  Waragai, Masaaki ^a   Lammers, Claas Hinrich ^b   Takeuchi, Sousuke ^a   Imafuku, Ichiro ^a   Udagawa, Yoshiyuki ^c   Kanazawa, Ichiro ^a   Kawabata, Masahiro ^c   Mouradian, M Maral ^b   Okazawa, Hitoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c CANCER INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; GLUTAMINE; RETINOIC ACID; TRANSCRIPTION FACTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL NUCLEUS; CELL SURVIVAL; CEREBELLUM CORTEX; CONTROLLED STUDY; EMBRYONAL CARCINOMA; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; OLFACTORY BULB; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ULTRAVIOLET IRRADIATION;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; BRAIN; CARRIER PROTEINS; CELL NUCLEUS; CELL SURVIVAL; DNA; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; IN SITU HYBRIDIZATION; MALE; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PEPTIDES; POU DOMAIN FACTORS; PROTEIN BINDING; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; TISSUE DISTRIBUTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRINUCLEOTIDE REPEATS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0033007323     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/8.6.977     Document Type: Article

References (45)

1. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell, 72, 971-983.
2. La Spada, A.R., Wilson, E.M., Lubahn, D.B., Harding, A.E. and Fischbeck, K.H. (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature, 352, 77-79.
3. Koide, R. et al. (1994) Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nature Genet., 6, 9-13.
4. Nagafuchi, S. et al. (1994) Structure and expression of the gene responsible for the triplet repeat disorder, dentatorubral and pallidoluysian-atrophy (DRPLA). Nature Genet., 8, 177-182.
5. Li, S.H., McInnis, M.G., Margolis, R.L., Antonarakis, S.E. and Ross, C.A. (1993) Novel triplet repeat containing genes in human brain: cloning, expression, and length polymorphisms. Genomics, 16, 572-579.
6. Margolis, R.L. et al. (1996) DRPLA gene (atrophin-1) sequence and mRNA expression in human brain. Brain Res. Mol. Brain Res., 36, 219-226.
7. Kawaguchi, Y. et al. (1994) CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nature Genet., 8, 221-228.
8. Orr, H.T. et al. (1993) Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nature Genet., 4, 221-226.
9. Pulst, S.-M. et al. (1996) Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nature Genet., 14, 269-276.
10. Sanpei, K. et al. (1996) Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nature Genet., 14, 277-284.
11. Imbert, G. et al. (1996) Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nature Genet., 14, 285-291.
12. Mangiarini, L. et al. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell, 87, 493-506.
13. Ikeda, H. et al. (1996) Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nature Genet., 13, 196-202.
14. Perutz, M.F., Johnson, T., Suzuki, M. and Finch, J.T. (1994) Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc. Natl Acad. Sci. USA, 91, 5355-5358.
15. Miyashita, T., Okamura-Oho, Y., Mito, Y., Nagafuchi, S. and Yamada, M. (1997) Dentatorubral pallidoluysian atrophy (DRPLA) protein is cleaved by caspase-3 during apoptosis. J. Biol. Chem., 272, 29238-29242.
16. Wellington, C.L. et al. (1998) Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J. Biol. Chem., 273, 9158-9167.
17. Scherzinger, E. et al. (1997) Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell, 90, 549-558.
18. Paulson, H.L. et al. (1997) Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron, 19, 333-344.
19. DiFiglia, M. et al. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neuntes in brain. Science, 277, 1990-1993.
20. Kahlem, P., Green, H. and Djian, P. (1998) Transglutaminase action imitates Huntington's disease: selective polymerization of Huntingtin containing expanded polyglutamine. Mol. Cell, 1, 595-601.
21. Igarashi, S. et al. (1998) Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nature Genet., 18, 111-117.
22. Li, X.J. et al. (1995) A huntingtin-associated protein enriched in brain with implications for pathology. Nature, 378, 398-402.
23. Kalchman, M.A. et al. (1997) HIP1, a human homologue of S.cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain. Nature Genet., 16, 44-53.
24. Burke, J.R. et al. (1996) Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nature Med., 2, 347-350.
25. Matilla, A. et al. (1997) The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1. Nature, 389, 974-978.
26. Trottier, Y. et al. (1995) Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature, 378, 403-406.
27. Imafuku, I., Kamei, M., Kanazawa, I., Mouradian, M.M. and Okazawa, H. (1996) POU transcription factors differentially regulate the D1A dopamine receptor gene in cultured cells. Biochem. Biophys. Res. Commun., 222, 736-741.
28. Okazawa, H. et al. (1996) Regulation of striatal D1A dopamine receptor gene transcription by Brn-4. Proc. Natl Acad. Sci. USA, 93, 11933-11938.
29. Imafuku, I. et al. (1998) Polar amino acid-rich sequences bind to polyglutamine tracts. Biochem. Biophys. Res. Commun., 253, 16-20.
30. Kozak, M. (1987) An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res., 15, 8125-8148.
31. Sudol, M. (1996) The WW module competes with the SH3 domain? Trends. Biochem. Sci., 21, 161-163.
32. Surowy, C.S., Hoganson, G., Gosink, J., Strunk, K. and Spritz, R.A. (1990) The human RD protein is closely related to nuclear RNA-binding proteins and has been highly conserved. Gene, 90, 299-302.
33. Chen, J.D. and Evans, R.M. (1995) A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature, 377, 454-457.
34. 2+-binding domain. J. Biol. Chem., 273, 15879-15882.
35. Wood, J.D. et al. (1998) Atrophin-1, the DRPLA gene product, interacts with two families of WW domain-containing proteins. Mol. Cell Neurosci., 11, 149-160.
36. Chawla, S., Hardingham, G.E., Quinn, D.R. and Bading, H. (1998) CBP: a signal-regulated transcriptional coactivator controlled by nuclear calcium and CaM kinase IV. Science, 281, 1505-1509.
37. Farber, P.W. et al. (1998) Huntingtin interacts with a family of WW domain proteins. Hum. Mol. Genet., 7, 1463-1474.
38. 1 and S phase protein phosphatase that associates with Cdk2. Cell, 75, 791-803.
39. Fujii, H. and Hamada, H. (1993) A CNS-specific POU transcription factor, Brn-2, is required for establishing mammalian neural cell lineages. Neuron, 11, 1197-1206.
40. Hara, Y., Rovescalli, A.C., Kim, Y. and Nirenberg, M. (1992) Structure and evolution of four POU domain genes expressed in mouse brain. Proc. Natl Acad. Sci. USA, 89, 3280-3284.
41. Okazawa, H. et al. (1991) The oct3 gene, a gene for an embryonic transcription factor, is controlled by a retinoic acid repressible enhancer. EMBO J., 10, 2997-3005.
42. Guarente, L. (1983) Yeast promoters and lacZ fusions designed to study expression of cloned genes in yeast. Methods Enzymol., 101, 181-191.
43. Bradley, D.J., Towle, H.C. and Young, W.S.III (1992) Spatial and temporal expression of alpha-and beta-thyroid hormone receptor mRNAs, including the beta 2-subtype, in the developing mammalian nervous system. J Neurosci., 12, 2288-2302.
44. Young, W.S.III, Kovacs, K. and Lolait, S.J. (1993) The diurnal rhythm in vasopressin V1a receptor expression in the suprachiasmatic nucleus is not dependent on vasopressin. Endocrinology, 133, 585-590.
45. Minowa, M.T., Minowa, T., Monsma, F.J.Jr, Sibley, D.R. and Mouradian, M.M. (1992) Characterization of the 5′ flanking region of the human D1A dopamine receptor gene. Proc. Natl Acad. Sci. USA, 89, 3045-3049.